PREVALENCE OF FOVEAL LESIONS IN TYPE-1 AND TYPE-2 USHERS SYNDROME

Purpose: To evaluate possible differences in the prevalence of clinically detectable foveal lesions between patients with type I and type 2 Usher's syndrome. Methods: Records of 48 patients with type 1 and 98 patients with type 2 Usher's syndrome were retrospectively evaluated for the presence of a foveal lesion. The age, gender, and racial distribution of patients were similar in the two subtypes. Two investigators reviewed fundus photographs from all patients and, when available, fluorescein angiograms. Results: In the 48 patients with type I Usher's syndrome, 30 (62%) showed a clinically apparent atrophic-or cystic-appearing foveal lesion, whereas in the 98 patients with type 2 Usher's syndrome, 33 (34%) had either an atrophic-or a cystic-appearing foveal lesion. Logistic regression analysis showed that the probability of exhibiting a foveal lesion in both type 1 and type 2 Usher's syndrome increases with age and that patients with type 1 Usher's syndrome are more likely to have a foveal lesion than are patients with type 2 Usher's syndrome. Conclusions: Patients with type 1 Usher's syndrome show a greater probability of having either an atrophic or cystic-appearing foveal lesion than do patients with type 2 Usher's syndrome. This higher prevalence of foveal lesions is consistent with a previous observation that the severity of visual acuity impairment with age is greater for patients with type 1 than type 2 Usher's syndrome. These data are useful in counseling such patients as to their prognosis for central visual function.